Risk factor status and vascular events in patients with symptomatic intracranial stenosis - PubMed (original) (raw)

Comparative Study

Risk factor status and vascular events in patients with symptomatic intracranial stenosis

S Chaturvedi et al. Neurology. 2007.

Abstract

Background: There are limited data on the relationship between control of vascular risk factors and vascular events in patients with symptomatic intracranial arterial stenosis.

Methods: We utilized the Warfarin Aspirin Symptomatic Intracranial Disease study database to analyze vascular and lifestyle risk factors at baseline and averaged over the course of the trial. Cutoff levels defining good control for each factor were prespecified based on national guidelines. Endpoints evaluated included 1) ischemic stroke, myocardial infarction, or vascular death or 2) ischemic stroke alone. Univariate associations were assessed using the log-rank test and multivariable analysis was done using Cox proportional hazards regression.

Results: From baseline until year 2 follow-up, there was not a significant improvement in blood pressure control. During the same period, there were improvements in patients with total cholesterol <200 mg/dL (54.6% to 79.2%, p < 0.001) or low-density lipoprotein <100 mg/dL (28.7% to 55.9%, p < 0.001). Multivariable analysis showed that systolic blood pressure >or=140 mm Hg (HR = 1.79, p = 0.0009, 95% confidence limits 1.27 to 2.52), no alcohol consumption (HR 1.69, 1.21 to 2.39, p = 0.002), and cholesterol >or=200 mg/dL (HR 1.44, 1.004 to 2.07, p = 0.048) were associated with an increased risk of stroke, myocardial infarction, or vascular death. The same risk factors were predictors of ischemic stroke alone in multivariable analysis.

Conclusions: Elevated blood pressure and cholesterol levels in symptomatic patients with intracranial stenosis are associated with an increased risk of stroke and other major vascular events.

PubMed Disclaimer

Cited by

Intracranial stenting: SAMMPRIS.
Derdeyn CP, Fiorella D, Lynn MJ, Turan TN, Lane BF, Janis LS, Chimowitz MI. Derdeyn CP, et al. Stroke. 2013 Jun;44(6 Suppl 1):S41-4. doi: 10.1161/STROKEAHA.111.000370. Stroke. 2013. PMID: 23709726 Free PMC article. Review.
Intracranial atherosclerotic disease.
Wang Y, Meng R, Liu G, Cao C, Chen F, Jin K, Ji X, Cao G. Wang Y, et al. Neurobiol Dis. 2019 Apr;124:118-132. doi: 10.1016/j.nbd.2018.11.008. Epub 2018 Nov 12. Neurobiol Dis. 2019. PMID: 30439443 Free PMC article. Review.
The challenge of stroke prevention with intracranial arterial stenosis.
Turan TN, Smock A, Chimowitz MI. Turan TN, et al. Curr Cardiol Rep. 2013 Dec;15(12):422. doi: 10.1007/s11886-013-0422-y. Curr Cardiol Rep. 2013. PMID: 24105641 Free PMC article. Review.
Rationale for ischemic conditioning to prevent stroke in patients with intracranial arterial stenosis.
Al Kasab S, Hess DC, Chimowitz MI. Al Kasab S, et al. Brain Circ. 2016 Apr-Jun;2(2):67-71. doi: 10.4103/2394-8108.186260. Epub 2016 Jul 13. Brain Circ. 2016. PMID: 30276275 Free PMC article. Review.
Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee.
Turan TN, Zaidat OO, Gronseth GS, Chimowitz MI, Culebras A, Furlan AJ, Goldstein LB, Gonzalez NR, Latorre JG, Messé SR, Nguyen TN, Sangha RS, Schneck MJ, Singhal AB, Wechsler LR, Rabinstein AA, Dolan O'Brien M, Silsbee H, Fletcher JJ. Turan TN, et al. Neurology. 2022 Mar 22;98(12):486-498. doi: 10.1212/WNL.0000000000200030. Neurology. 2022. PMID: 35314513 Free PMC article.

Risk factor status and vascular events in patients with symptomatic intracranial stenosis - PubMed (original) (raw)